People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amprion, Inc. | — | Biotechnology | Series A | $16.7M | $27.6M | 2024 |
| LeviSense Medical, Inc. | — | Healthtech | Pre-Seed | $270K | $3.9M | 2022 |
Rahul Bhansali at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rahul Bhansali on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gary Magnant | 1 | 5 |
| Russell Lebovitz | 1 | 3 |
| Peter Rock | 1 | 2 |
| Peter Clinton | 1 | 1 |
| Kenneth Lehman | 1 | 1 |
| David Bertoni | 1 | 1 |
| Michael McGarrity | 1 | 1 |
| Donald Dye | 1 | 1 |
| Marc Chan | 1 | 1 |
| Claudio Soto | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.